Related Experiment Video
Updated: Apr 5, 2026

Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
Published on: May 31, 2018
Prenatal characteristics and postnatal outcomes of small fetal hepatic lesions: a retrospective cohort study
Sophia Heiman1,2, Batia Weiss3,2, Shayan Yousefi2,4
1Pediatric Gastroenterology, Hepatology and Nutrition, The Edmond and Lily Safra Children's Hospital, Tel HaShomer, Israel sophiaheiman1@gmail.com.
Objective:
To describe prenatal characteristics and postnatal outcomes of fetal hepatic lesions diagnosed on prenatal ultrasound and to identify prognostic factors of this condition.
Methods:
A retrospective study was conducted in a cohort of fetuses diagnosed with hepatic lesions between 2011 and 2023 at a tertiary referral center. Prenatal and postnatal data were collected, including lesion type, size, gestational age at detection, associated anomalies, genetic abnormalities, growth restriction and pregnancy outcomes. Postnatal follow-up included imaging, lesion resolution and overall health status.
Results:
65 fetuses were identified. Most lesions were echogenic (n=55); a minority were cystic (n=7), mixed (n=1) or subcapsular hematomas (n=2). Multiple lesions were present in 38%. Stillbirths, including fetal death and pregnancy termination, occurred in 18%, predominantly in the setting of major associated anomalies, fetal growth restriction and/or genetic abnormalities. Of 48 liveborn infants, 96% were healthy at discharge. Among 31 infants followed postnatally, 75% showed lesion resolution by 21 months. At the 5-year median follow-up, 79% were healthy. Echogenic lesions were more common in healthy infants, while a cystic component was associated with a higher rate of concurrent clinically significant health conditions, although liver function was typically normal.
Conclusion:
Isolated small echogenic fetal hepatic lesions display a favorable prognosis with spontaneous resolution in most cases. Adverse pregnancy outcomes are common in cases with associated anomalies, fetal growth restriction and genetic abnormalities; therefore, counseling should be guided by a comprehensive anomaly assessment and appropriate genetic evaluation.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

